BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease

BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease

FRANKLIN LAKES, N.J., May 28, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to initiate a patient data registry for the Rotarex™ Atherectomy System to measure real-world outcomes for…

BD to initiate real-world patient registry for Rotarex atherectomy system - Interventional News

Rotarex atherectomy system BD has announced plans to initiate a patient data registry for the Rotarex atherectomy system to measure real-world outcomes for patients with peripheral arterial disease (PAD). Known as XTRACT, this prospective, multicentre, single-arm, post-market registry study will assess the clinical performance of the Rotarex atherectomy system in the treatment of US patients with PAD lesions. The XTRACT Registry is being led in …

BD to launch registry study of atherectomy system for PAD treatment

BD is set to commence a multi-centre registry study, XTRACT, of the Rotarex Atherectomy System, for peripheral artery disease (PAD).The post BD to launch registry study of atherectomy system for PAD treatment appeared first on Medical Device Network.

BD Rotarex to Be Assessed in XTRACT Postmarket Registry - Endovascular Today

May 28, 2025—BD (Becton, Dickinson and Company) announced plans to initiate the XTRACT patient data registry for its Rotarex atherectomy system. The registry will measure real-world outcomes with the device in the treatment of patients with peripheral artery disease (PAD) in the United States. According to the company, the prospective, multicenter, single-arm XTRACT postmarket registry will assess the clinical performance of Rotarex in treating …

BD To Initiate Real-World Patient Data Registry For The Rotarex™ Atherectomy System In Treatment Of Peripheral Artery Disease - Medical Device News Magazine

Known as "XTRACT," this prospective, multi-center, single-arm, post-market registry study will assess the clinical performance of the Rotarex™ Atherectomy System in the treatment of U.S. patients with PAD lesions.